MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4Jiaxin Lin, Min Zheng, Lan Zhang et al.|Oncotarget|2015Cited by 59
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphomaXiao‐Peng Tian, Qingqing Cai, Xianhuo Wang et al.|Cell Reports Medicine|2023Cited by 21
The INSPECTOR study: enhanced feasibility for clinical translation of a multi‐cancer early detection method based on enzyme‐assisted high signal‐to‐noise ratio sequencing of methylated circulating tumor DNAHui Luo, Rui‐Hua Xu, Wei Wei et al.|癌症：英文版|2025Cited by 5
Anlotinib combined with pemetrexed as a further treatment of patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II studyJueming Chen, Yanna Zhang, Wei Wei et al.|Gynecologic Oncology|2021Cited by 2
Anlotinib (AL3818) plus pemetrexed in patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A single-arm, open-label, phase II study.Yanna Zhang, He Huang, Jueming Chen et al.|Journal of Clinical Oncology|2020Cited by 1